XBIOTECH INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
XBIOTECH INC. (XBIT) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 81.00% for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2026-08-13
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2026-06-30 was 81.00%.
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2025-09-30 was 79.00%, a 0.00% change year-over-year.
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2025-06-30 was 0.00%.
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2024-09-30 was 79.00%.
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2022 was 0.00%.
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2020 was 0.00%.
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2013 was 73.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month |
|---|---|---|
| 2026-06-30 | 81.00% 10-Q · filed 2026-08-13 | |
| 2025-09-30 | 79.00% 10-Q · filed 2025-11-12 | |
| 2025-06-30 | 0.00% 10-Q · filed 2026-08-13 | |
| 2024-09-30 | 79.00% 10-Q · filed 2025-11-12 | |
| 2024-03-31 | 80.00% 10-Q · filed 2025-05-14 | |
| 2023-06-30 | 81.00% 10-Q · filed 2024-08-12 | |
| 2023-03-31 | 82.00% 10-Q · filed 2024-05-10 | |
| 2022-12-31 | 0.00% 10-K · filed 2023-03-15 | |
| 2022-09-30 | 83.00% 10-Q · filed 2023-11-09 | |
| 2022-06-30 | 83.00% 10-Q · filed 2023-08-11 | |
| 2020-12-31 | 0.00% 10-K · filed 2022-03-15 | |
| 2020-09-30 | 87.00% 10-Q · filed 2021-11-09 | |
| 2020-06-30 | 88.00% 10-Q · filed 2021-08-09 | |
| 2019-06-30 | 91.00% 10-Q · filed 2020-08-10 | |
| 2018-06-30 | 80.00% 10-Q · filed 2019-08-09 | |
| 2017-09-30 | 67.00% 10-Q · filed 2018-10-31 | |
| 2017-06-30 | 67.00% 10-Q · filed 2018-08-09 | |
| 2016-09-30 | 70.00% 10-Q · filed 2017-11-09 | |
| 2015-09-30 | 66.00% 10-Q · filed 2016-11-14 | |
| 2015-06-30 | 71.00% 10-Q · filed 2016-08-12 | |
| 2015-03-31 | 68.00% 10-Q · filed 2016-05-13 | |
| 2014-03-31 | 70.00% 10-Q · filed 2015-06-18 | |
| 2013-12-31 | 73.00% 10-K · filed 2016-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |